Cardiovascular Diabetology

MAY 2, 2024

Insulin resistance and chronic kidney disease are both associated with increased coronary artery disease risk. Many formulae estimating glucose disposal rate in type 1 diabetes infer insulin sensitivity from c.

Coronary Artery Disease 124

Coronary Artery Disease Diabetes Kidney Disease Research 124

Cardiovascular Diabetology

FEBRUARY 14, 2025

People living with diabetes mellitus (DM) and chronic kidney disease (CKD) are at significantly high risk of cardiovascular events (CVEs), however the predictive performance of traditional risk prediction meth.

Kidney Disease 76

Kidney Disease Diabetes Research 76

HCPLive

JANUARY 19, 2024

Evidence from the Look AHEAD study suggests achieving remission in type 2 diabetes is associated with risk reductions in chronic kidney disease and cardiovascular disease.

Diabetes 111

Diabetes Kidney Disease Cardiovascular Disease 111

HCPLive

DECEMBER 14, 2023

Continuous glucose monitoring metrics showed that patients with burnt-out diabetes and end-stage kidney disease experience significant undiagnosed hyperglycemia.

Diabetes 105

Diabetes Kidney Disease 105

HCPLive

DECEMBER 21, 2023

A new study is raising awareness around the effects of structural racism on the prevalence of chronic health conditions.

Kidney Disease 122

Kidney Disease Cardiovascular Disease Diabetes 122

Cardiovascular Diabetology

MARCH 21, 2025

Mineralocorticoid receptor antagonists (MRAs) are often underutilized in patients with heart failure (HF), particularly those with diabetes and/or chronic kidney disease (CKD). However, the impact of concurren.

Kidney Disease 59

Kidney Disease Heart Failure Diabetes Hospital 59

HCPLive

NOVEMBER 13, 2024

People with diabetes, kidney stones, damaged joints, high uric acids, and daily use of NSAID were more likely to develop CKD than others.

Kidney Disease 105

Kidney Disease Diabetes 105

Med Page Today

OCTOBER 29, 2024

(MedPage Today) -- SAN DIEGO -- Semaglutide (Wegovy) reduced albuminuria in patients with overweight or obesity and chronic kidney disease (CKD) but without type 2 diabetes, a randomized trial showed. Among 101 patients, those who received 2.

Diabetes 90

Diabetes Kidney Disease Obesity 90

Med Page Today

JUNE 20, 2024

(MedPage Today) -- People with systemic lupus erythematosus (SLE) had lower rates of lupus nephritis, chronic kidney disease, and other complications when they were taking metformin, an analysis of medical records indicated. Among some 88,000.

Kidney Disease 113

Kidney Disease Diabetes 113

HCPLive

MARCH 26, 2024

A study in China identified a negative and non-linear relationship between hemoglobin levels and a renal composite end point in patients with DKD.

Kidney Disease 98

Kidney Disease Diabetes Outcomes 98

Medical Xpress - Cardiology

FEBRUARY 14, 2025

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.

Heart Attack 139

Heart Attack Heart attacks Research Kidney Disease 139

HCPLive

MAY 25, 2024

Hosts break down the FLOW trial, take a deep dive into secondary findings, and provide insight into how this alters the perception of the role for semaglutide in management of CKD in type 2 diabetes.

Kidney Disease 75

Kidney Disease Diabetes 75

Cardiovascular Diabetology

APRIL 24, 2024

This study was designed to assess the associations between emerging cardiometabolic indices—the atherogenic index of plasma (AIP), the stress hyperglycemia ratio (SHR), the triglyceride-glucose (TyG) index, an.

Kidney Disease 98

Kidney Disease Diabetes Research 98

The New England Journal of Medicine

MARCH 28, 2025

Among participants with type 2 diabetes and cardiovascular disease, chronic kidney disease, or both, oral semaglutide (14 mg) was associated with a lower risk of cardiovascular events than placebo after 4 years of follow-up.

Diabetes 75

Diabetes Kidney Disease Cardiovascular Disease Outcomes 75

Cardiovascular Diabetology

JANUARY 8, 2024

Myocardial infarction (MI), stroke, peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Myocardial Infarction Kidney Disease Diabetes 105

Cardiovascular Diabetology

MARCH 27, 2025

Cardiovascular Autonomic Neuropathy (CAN) is one of the most devastating complications of Diabetes Mellitus (DM) and presents high morbidity and mortality. Its association with diabetic kidney disease (DKD) wo.

Kidney Disease 52

Kidney Disease Diabetes Research 52

HCPLive

MARCH 21, 2024

In this episode, Neuen talks about the FLOW trial, the concept of 4 pillars of GDMT for CKD in type 2 diabetes, and how to approach sequencing of these therapies.

Kidney Disease 83

Kidney Disease Diabetes 83

Cardiovascular Diabetology

OCTOBER 8, 2024

Most existing risk equations for predicting/stratifying individual diabetic kidney disease (DKD) risks were developed using relatively dated data from selective and homogeneous trial populations comprising pre.

Kidney Disease 52

Kidney Disease Diabetes Research 52

American Heart News - Heart News

FEBRUARY 18, 2025

adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, kidney disease, type 2 diabetes and obesity.[1] DALLAS, Feb. 18, 2025 About 90% of U.S. 1] This cluster of chronic health conditions is called.

Kidney Disease 118

Kidney Disease Obesity Heart Disease Diabetes 118

Science Daily - Heart Disease

FEBRUARY 14, 2025

New research shows sotagliflozin is the only drug in its class to demonstrate these results.

Heart Attack 112

Heart Attack Heart attacks Kidney Disease Heart Failure 112

Cardiovascular Diabetology

JUNE 14, 2024

Diabetic kidney disease is an established risk factor for heart failure. However, the impact of incident heart failure on the subsequent risk of renal failure has not been systematically assessed in diabetic p.

Kidney Disease 52

Kidney Disease Heart Failure Diabetes Risk Factors 52

CardiacWire

MAY 8, 2024

A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease. Stage 4 (heart disease, with or without kidney disease) – 9.2% in Whites).

Kidney Disease 116

Kidney Disease Obesity Risk Factors Diabetes 116

Journal of the American Heart Association

FEBRUARY 16, 2024

BackgroundInhibition of prostaglandin synthesis by nonsteroidal anti‐inflammatory drugs is associated with cardiovascular mortality and kidney disease. Longitudinal associations with cardiovascular mortality and kidney outcomes (eGFR <60 or <45 mL/min per 1.73 1.54]; PGEM HR, 1.36 [95% CI, 1.10–1.67]).

Kidney Disease 73

Kidney Disease Risk Factors Outcomes Diabetes 73

Cardiovascular Diabetology

AUGUST 6, 2024

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.

Coronary Artery Disease 98

Coronary Artery Disease Diabetes Myocardial Infarction Heart Failure 98

HCPLive

JANUARY 30, 2025

Garimella describes the overlap between diabetes and kidney disease, explaining the significance of semaglutides new indication for these patients.

Diabetes 69

Diabetes Kidney Disease 69

HCPLive

JANUARY 30, 2025

In this episode, hosts discuss the approval of semaglutide (Ozempic) for reducing the progression of kidney disease in type 2 diabetes.

Diabetes 64

Diabetes Kidney Disease 64

Cardiovascular Diabetology

APRIL 9, 2024

Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes and is often acc.

Kidney Disease 64

Kidney Disease Hypertension Public Health Diabetes 64

Cardiovascular Diabetology

JULY 3, 2024

Despite improved glycemic treatment, the impact of glycation on pathological consequences may persist and contribute to adverse clinical outcomes in diabetes. In the present study we.

Diabetes 64

Diabetes Kidney Disease Outcomes Research 64

The New England Journal of Medicine

FEBRUARY 6, 2025

This report describes the transplantation of a gene-edited porcine kidney in a hemodialysis-dependent man with long-standing diabetes, advanced vasculopathy, and marked dialysis-access challenges.

Kidney Disease 75

Kidney Disease Transplant Diabetes 75

HCPLive

NOVEMBER 11, 2024

Panelists discuss the criteria for identifying at-risk patients for chronic kidney disease (CKD) testing in type 2 diabetes and review the screening and detection tests, emphasizing the critical importance of early detection through blood and urine tests for both CKD management and heart failure prevention.

Kidney Disease 98

Kidney Disease Heart Failure Diabetes 98

HCPLive

AUGUST 31, 2024

Kenneth Mahaffey, MD, discusses FLOW trial data showing semaglutide improves cardiovascular outcomes in patients with type 2 diabetes, regardless of CKD severity.

Kidney Disease 72

Kidney Disease Diabetes Outcomes 72

HCPLive

OCTOBER 25, 2024

New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.

Kidney Disease 64

Kidney Disease Diabetes Research 64

Cardiovascular Diabetology

JANUARY 2, 2024

The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance and previous studies have confirmed the association of TyG index with incident chronic kidney disease (CKD). However, t.

Kidney Disease 59

Kidney Disease Diabetes Research 59

Cardiovascular Diabetology

DECEMBER 12, 2023

In the last years, the classical pattern of diabetic kidney disease (DKD) has been partially overcome, because of the uncovering of a new DKD phenotype with significant renal dysfunction without presence of al.

Kidney Disease 40

Kidney Disease Diabetes Research 40

Hypertension Journal

DECEMBER 7, 2023

ETs were shown to play important roles among others, in systemic hypertension, particularly when resistant or difficult to control, and in pulmonary hypertension, atherosclerosis, cardiac hypertrophy, subarachnoid hemorrhage, chronic kidney disease, diabetic cardiovascular disease, scleroderma, some cancers, etc.

Kidney Disease 45

Kidney Disease Hypertension Pulmonary Atherosclerosis 45

HCPLive

DECEMBER 30, 2024

Panelists discuss how health care providers can effectively utilize white papers and other tools in practice, as well as additional resources available for further learning about chronic kidney disease (CKD) and type 2 diabetes management.

Diabetes 52

Diabetes Education Kidney Disease 52

Cardiovascular Diabetology

OCTOBER 23, 2024

A Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) formula not including a Black race coefficient has been recently developed and is now recommended in the US. The new (2021) equation was shown to.

Kidney Disease 52

Kidney Disease Diabetes Research 52